RUMORED BUZZ ON ABBV-744 FOR SMALL CELL LUNG CANCER RESEARCH

The current work examined the potential of using ARV-825 and ABBV-744 to improve the effectiveness of tamoxifen or fulvestrant plus palbociclib. ARV-825 was effective in equally p53 wild-type (WT) breast tumor cells and in cells lacking practical p53 either alone or in combination with tamoxifen, even though the effectiveness of ABBV-744 was restri